Home/Filings/4/0001127602-21-015362
4//SEC Filing

Louie Linda H. 4

Accession 0001127602-21-015362

CIK 0000318154other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 7:35 PM ET

Size

10.9 KB

Accession

0001127602-21-015362

Insider Transaction Report

Form 4
Period: 2021-04-30
Louie Linda H.
VP, Finance & CAO
Transactions
  • Award

    Common Stock

    2021-04-30+3008,301 total
  • Award

    Nqso (Right to Buy)

    2021-04-30+2,6082,608 total
    Exercise: $239.64From: 2023-04-30Exp: 2031-04-30Common Stock (2,608 underlying)
  • Tax Payment

    Common Stock

    2021-05-01$239.64/sh18$4,3148,283 total
  • Tax Payment

    Common Stock

    2021-05-03$239.64/sh17$4,0748,266 total
Footnotes (4)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively.
  • [F2]These shares include the following RSUs granted under the Company's equity plans: 58 RSUs which will vest on 4/27/2022; 132 RSUs which vest in installments of 65 on 5/3/2022 and 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment of 495 on 11/2/2024; and 300 RSUs which vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 42 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F4]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001818953

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 7:35 PM ET
Size
10.9 KB